Clinical Trial Update: Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab with paclitaxel and cisplatin versus paclitaxel and cisplatin alone as first-line therapy for metastatic esophageal squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Peking University | Conditions: Esophageal Cancer, Squamous Cell, Cetuximab Effect | Phase 2 | Status: UNKNOWN